Literature DB >> 15871006

[Lymphadenectomy for bladder cancer. Diagnostic and prognostic significance as well as therapeutic benefit].

J Leissner1.   

Abstract

BACKGROUND: Pelvic lymphadenectomy for invasive bladder cancer is not a standardized procedure and its relevance for staging and prognoses is still under discussion. A number of retrospective studies have demonstrated a positive correlation between extent of lymphadenectomy and prognosis after radical cystectomy.
MATERIALS AND METHODS: In a retrospective study, we correlated the extent of lymphadenectomy with survival after radical cystectomy. Thereafter, we conducted a prospective study to investigate the limits of pelvic lymphadenectomy and the pattern of lymphatic spread.
RESULTS: Retrospectively, we found a significantly better survival for patients when 15 and more lymph nodes were removed. The individual surgeon was also evaluated as an important prognostic factor.
CONCLUSIONS: Based on retrospective data, an extended and complete pelvic lymphadenectomy improves the prognosis. The cranial border should be at least at the level of the aortic bifurcation. A prospective randomized study will have to clarify the effect of lymphadenectomy on the prognosis of patients after radical cystectomy.

Entities:  

Mesh:

Year:  2005        PMID: 15871006     DOI: 10.1007/s00120-005-0827-3

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  13 in total

1.  Impact of separate versus en bloc pelvic lymph node dissection on the number of lymph nodes retrieved in cystectomy specimens.

Authors:  B H Bochner; H W Herr; V E Reuter
Journal:  J Urol       Date:  2001-12       Impact factor: 7.450

2.  Proceedings: Total cystectomy. An editorial overview.

Authors:  D M Wallace
Journal:  Cancer       Date:  1973-11       Impact factor: 6.860

3.  Extended lymph-node dissection for gastric cancer.

Authors:  J J Bonenkamp; J Hermans; M Sasako; C J van de Velde; K Welvaart; I Songun; S Meyer; J T Plukker; P Van Elk; H Obertop; D J Gouma; J J van Lanschot; C W Taat; P W de Graaf; M F von Meyenfeldt; H Tilanus
Journal:  N Engl J Med       Date:  1999-03-25       Impact factor: 91.245

4.  Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder; significance for staging and prognosis.

Authors:  J Leissner; R Hohenfellner; J W Thüroff; H K Wolf
Journal:  BJU Int       Date:  2000-05       Impact factor: 5.588

Review 5.  The importance of an extended lymphadenectomy in the management of high-grade invasive bladder cancer.

Authors:  Marcus L Quek; Kristin M Sanderson; Siamak Daneshmand; John P Stein
Journal:  Expert Rev Anticancer Ther       Date:  2004-12       Impact factor: 4.512

6.  Surgical factors influence bladder cancer outcomes: a cooperative group report.

Authors:  Harry W Herr; James R Faulkner; H Barton Grossman; Ronald B Natale; Ralph deVere White; Michael F Sarosdy; E David Crawford
Journal:  J Clin Oncol       Date:  2004-06-15       Impact factor: 44.544

7.  Does extended lymphadenectomy increase the morbidity of radical cystectomy?

Authors:  C Brössner; A Pycha; A Toth; C Mian; W Kuber
Journal:  BJU Int       Date:  2004-01       Impact factor: 5.588

8.  Management of invasive bladder cancer: a meticulous pelvic node dissection can make a difference.

Authors:  D G Skinner
Journal:  J Urol       Date:  1982-07       Impact factor: 7.450

9.  Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density.

Authors:  John P Stein; Jie Cai; Susan Groshen; Donald G Skinner
Journal:  J Urol       Date:  2003-07       Impact factor: 7.450

10.  Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group.

Authors:  A Cuschieri; S Weeden; J Fielding; J Bancewicz; J Craven; V Joypaul; M Sydes; P Fayers
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

View more
  1 in total

Review 1.  [Urothelial carcinoma].

Authors:  H Rübben; F Vom Dorp
Journal:  Urologe A       Date:  2011-09       Impact factor: 0.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.